# Baden Prevention and Reduction of Incidence of Postoperative Delirium Trial

> **NCT02433041** · PHASE4 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 200 (actual)

## Conditions studied

- Postoperative Delirium

## Interventions

- **DRUG:** Haloperidol
- **DRUG:** Ketamine
- **DRUG:** Haloperidol + Ketamine
- **DRUG:** Saline solution (NaCl 0.9%)

## Key facts

- **NCT ID:** NCT02433041
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2018-12-21
- **Final completion:** 2018-12-21
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2019-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02433041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02433041, "Baden Prevention and Reduction of Incidence of Postoperative Delirium Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02433041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*